Advertisement

AIDS and Behavior

, Volume 23, Issue 4, pp 920–928 | Cite as

Late Presentation and Missed Opportunities for HIV Diagnosis in Guatemala

  • Johanna MeléndezEmail author
  • Samuel W. Reinhardt
  • Jane A. O’Halloran
  • Andrej SpecEmail author
  • Andrea Alonzo Cordon
  • William G. Powderly
  • Carlos Mejia Villatoro
Original Paper

Abstract

Early HIV diagnosis remains a challenge in many regions with delayed diagnosis resulting in increased morbidity and mortality. We conducted a retrospective cohort study of people living with HIV receiving outpatient care at a large tertiary referral center in Guatemala to describe the proportion of late presenters (LP) and missed opportunities for HIV diagnosis. Of 3686 patients, 2990 (81.1%) were LP who were more likely to be male (60.2% vs. 48.0%, p < 0.0001), heterosexual (88.0% vs. 78.0%, p < 0.0001) and rural dwellers (43.7% vs. 33.8%. p < 0.0001). The proportions of patients who presented late or with AIDS at diagnosis decreased over time. Only 665 patients (18.2%) sought care in the 2 years prior to HIV diagnosis. This study, the first of its kind in Central America to focus on late presenters and missed opportunities for HIV diagnosis, demonstrates extremely high rates of LP in Guatemala. Although in recent years rates of LP have improved somewhat, the need for screening outside of traditional healthcare settings is apparent.

Keywords

HIV Guatemala Diagnosis AIDS 

Resumen

El diagnóstico precoz del VIH sigue siendo un desafío en muchas regiones, y un diagnóstico tardío está relacionado con aumento de la morbi-mortalidad. Este estudio retrospectivo de una cohorte de personas viviendo con VIH en seguimiento en un centro atención terciaria en ciudad de Guatemala, describe la proporción de presentadores tardíos (PT) y las oportunidades perdidas para diagnosticarlas. De 3686 pacientes analizados, 2990 (81.1%) eran PT, los cuales eran con mayor frecuencia varones (60.2% vs. 48.0%, p < 0.0001), heterosexuales (88.0% vs. 78.0%, p < 0.0001) y habitantes de un área rural (43.7% vs. 33.8%. p < 0.0001). La proporción de PT disminuyó a lo largo del tiempo. Únicamente 665 pacientes (18.2%) buscaron atenciٕón médica en los dos años previos al diagnóstico del VIH. Este estudio, el primero en Centro América en enfocarse en presentadores tardios y oportunidades perdidas en el diagnostico del VIH, demuestra una tasa extremadamente alta de PT en Guatemala. A pesar de que en años recientes la tasa de PT ha mejorado, es evidente la necesidad de realizar tamizaje fuera del ambiente sanitario habitual.

Notes

Funding

Research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.

Compliance with Ethical Standards

Conflict of interest

WP has received research grants through his institution from Merck & Co. and has served on advisory board for Merck & Co. and Gilead Sciences. JM, SR, JOH, AS and AAC declare that they have no relevant conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

10461_2018_2331_MOESM1_ESM.docx (16 kb)
Supplementary material 1 (DOCX 15 kb)

References

  1. 1.
    Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013;27(6):973–9.CrossRefGoogle Scholar
  2. 2.
    May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28(8):1193–202.CrossRefGoogle Scholar
  3. 3.
    Fleishman JA, Yehia BR, Moore RD, Gebo KA, Network HIVR. The economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–9.CrossRefGoogle Scholar
  4. 4.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefGoogle Scholar
  5. 5.
    Heymer KJ, Wilson DP. Treatment for prevention of HIV transmission in a localised epidemic: the case for South Australia. Sex Health. 2011;8(3):280–94.CrossRefGoogle Scholar
  6. 6.
    Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, et al. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49(3):282–6.CrossRefGoogle Scholar
  7. 7.
    Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(Suppl 1):S3–8.CrossRefGoogle Scholar
  8. 8.
    Manavi K, McMillan A, Ogilvie M, Scott G. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS. 2004;15(12):811–4.CrossRefGoogle Scholar
  9. 9.
    Crabtree-Ramirez B, Caro-Vega Y, Belaunzaran-Zamudio F, Sierra-Madero J. High prevalence of late diagnosis of HIV in Mexico during the HAART era. Salud Publica Mex. 2012;54(5):506–14.CrossRefGoogle Scholar
  10. 10.
    Chin T, Hicks C, Samsa G, McKellar M. Diagnosing HIV infection in primary care settings: missed opportunities. AIDS Patient Care STDS. 2013;27(7):392–7.CrossRefGoogle Scholar
  11. 11.
    Volberding P. Sande’s HIV/AIDS medicine. Global care. 2nd ed, International edition. Edinburgh: Elsevier/Saunders; 2012.Google Scholar
  12. 12.
    Koh KC, Islam M, Chan WK, Lee WY, Ho YW, Alsagoff SAH, et al. Missed opportunities for earlier HIV-testing in patients with HIV infection referred to a tertiary hospital, a cross-sectional study. Med J Malays. 2017;72(4):209–14.Google Scholar
  13. 13.
    Martin-Onraet A, Volkow-Fernandez P, Alvarez-Wyssmann V, Gonzalez-Rodriguez A, Casillas-Rodriguez J, Rivera-Abarca L, et al. Late diagnosis due to missed opportunities and inadequate screening strategies in HIV infected Mexican women. AIDS Behav. 2017;21(2):505–14.CrossRefGoogle Scholar
  14. 14.
    Joint United Nations Programme on HIV/AIDS (UNAIDS). Country Factsheets: Guatemala. 2016. http://www.unaids.org/en/regionscountries/countries/guatemala
  15. 15.
    World Health Organization. Guatemala: WHO Statistical Profile. 2015.Google Scholar
  16. 16.
    Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged < 18 months and for HIV infection and AIDS among children aged 18 months to < 13 years-United States, 2008. MMWR Recomm Rep. 2008;57(RR-10):1–12.Google Scholar
  17. 17.
    Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.CrossRefGoogle Scholar
  18. 18.
    Garcia JI, Samayoa B, Sabido M, Prieto LA, Nikiforov M, Pinzon R, et al. The MANGUA project: a population-based HIV cohort in Guatemala. AIDS Res Treat. 2015;2015:372816.Google Scholar
  19. 19.
    Levy I, Maor Y, Mahroum N, Olmer L, Wieder A, Litchevski V, et al. Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study. BMJ Open. 2016;6(11):e012721.CrossRefGoogle Scholar
  20. 20.
    Nakao JH, Wiener DE, Newman DH, Sharp VL, Egan DJ. Falling through the cracks? Missed opportunities for earlier HIV diagnosis in a New York City Hospital. Int J STD AIDS. 2014;25(12):887–93.CrossRefGoogle Scholar
  21. 21.
    Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, et al. Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. BMC Infect Dis. 2013;13:200.CrossRefGoogle Scholar
  22. 22.
    Klein D, Hurley LB, Merrill D, Quesenberry CP Jr, Consortium for HIVAIR. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection implications for early detection. J Acquir Immune Defic Syndr. 2003;32(2):143–52.CrossRefGoogle Scholar
  23. 23.
    Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004;19(4):349–56.CrossRefGoogle Scholar
  24. 24.
    McDonald EA, Currie MJ, Bowden FJ. Delayed diagnosis of HIV: missed opportunities and triggers for testing in the Australian Capital Territory. Sex Health. 2006;3(4):291–5.CrossRefGoogle Scholar
  25. 25.
    Xie J, Hsieh E, Sun MQ, Wang HL, Lv W, Fan HW, et al. Delays in HIV diagnosis and associated factors among patients presenting with advanced disease at a tertiary care hospital in Beijing, China. PLoS ONE. 2017;12(8):e0182335.CrossRefGoogle Scholar
  26. 26.
    Gullon A, Verdejo J, de Miguel R, Gomez A, Sanz J. Factors associated with late diagnosis of HIV infection and missed opportunities for earlier testing. AIDS Care. 2016;28(10):1296–300.CrossRefGoogle Scholar
  27. 27.
    Liggett A, Medina N, Samayoa B, Mercado D, Castillo M, Argueta E, et al. Is expanded HIV testing associated with earlier HIV diagnosis? Results from an HIV clinic in Guatemala City. J Int Assoc Provid AIDS Care. 2016;15(3):201–4.CrossRefGoogle Scholar
  28. 28.
    Reinhardt SW, Spec A, Melendez J, Alonzo Cordon A, Ross I, Powderly WG, et al. AIDS-defining illnesses at initial diagnosis of HIV in a large Guatemalan cohort. Open Forum Infect Dis. 2017;4(4):ofx249.CrossRefGoogle Scholar
  29. 29.
    Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Sawires S, et al. Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS ONE. 2011;6(7):e21794.CrossRefGoogle Scholar
  30. 30.
    UNAIDS. AIDSinfo. 2015. www.aidsinfo.unaids.org.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Johanna Meléndez
    • 1
    Email author
  • Samuel W. Reinhardt
    • 2
  • Jane A. O’Halloran
    • 3
  • Andrej Spec
    • 3
    Email author
  • Andrea Alonzo Cordon
    • 1
  • William G. Powderly
    • 3
  • Carlos Mejia Villatoro
    • 1
  1. 1.Department of Internal Medicine, Infectious Diseases ClinicRoosevelt HospitalGuatemala CityGuatemala
  2. 2.Department of MedicineWashington University School of MedicineSt. LouisUSA
  3. 3.Division of Infectious DiseasesWashington University School of MedicineSt. LouisUSA

Personalised recommendations